0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lipid Contract Manufacturing Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38P6603
Home | Market Reports | Health| Pharmacy
Global Lipid Contract Manufacturing Market Insights Forecast to 2028
BUY CHAPTERS

Global Lipid Contract Manufacturing Market Research Report 2025

Code: QYRE-Auto-38P6603
Report
March 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lipid Contract Manufacturing Market Size

The global market for Lipid Contract Manufacturing was valued at US$ 824 million in the year 2024 and is projected to reach a revised size of US$ 770 million by 2031, growing at a CAGR of -1.0% during the forecast period.

Lipid Contract Manufacturing Market

Lipid Contract Manufacturing Market

Liposomes and lipid nanoparticles (LNPs) are similar by design, but slightly different in composition and function. Both are lipid nanoformulations and excellent drug delivery vehicles, transporting cargo of interest within a protective, outer layer of lipids. In application, however, LNPs can take a variety of forms.Innovators in the biopharmaceutical industry have developed a number of ways to improve/augment physiochemical properties and ultimately, the drug-like behavior of pharmacological substances. Amidst other alternatives, lipid nanoparticles and liposomes are the main type.Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.Liposomes and Lipid Nanoparticles are delivery carriers, the primary lipids used to make liposomes or Lipid Nanoparticles are Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids, etc. In our report, we mainly study the Liposomes and Lipid Nanoparticles (LNP) Contract Manufacturing as delivery carriers.
The lipid contract manufacturing market is primarily driven by the increasing demand for lipid-based formulations, particularly in the pharmaceutical, biotechnology, and nutraceutical industries. Lipid-based drug delivery systems, such as liposomes, lipid nanoparticles, and micelles, are gaining popularity due to their ability to improve the bioavailability, stability, and targeted delivery of drugs, especially in the treatment of cancer, autoimmune diseases, and other chronic conditions. Additionally, the growing trend of outsourcing production to contract manufacturers helps pharmaceutical and biotechnology companies focus on their core competencies while benefiting from specialized manufacturing expertise, cost efficiency, and scalability. The rise in research and development activities related to lipid formulations further fuels the market growth, as companies seek contract manufacturers with the capability to produce high-quality lipid products at scale.
However, the lipid contract manufacturing market faces challenges related to the complexity and cost of lipid-based formulations. Developing and manufacturing lipid formulations often requires specialized knowledge, sophisticated technology, and stringent quality control processes, which can increase production costs. The market also experiences regulatory challenges, as lipid-based products, particularly those used in drug delivery, need to meet rigorous safety and efficacy standards, which may vary across different regions. Additionally, the scalability of lipid-based production can be a limitation, as certain formulations require careful handling and precision, making large-scale manufacturing more difficult and costly. These factors necessitate continued innovation and investment in advanced manufacturing techniques to overcome these challenges and meet market demands.
Global core lipid contract manufacturing companies include Merck KGaA, Exelead and Avanti Polar Lipids etc. The top 3 companies hold a share about 38%. North America is the largest market, with a share over 60%, followed by Europe and APAC with the share about 26% and 12%. In terms of product, lipid nanoparticles is the largest segment with a share about 79%. And in terms of application, the largest application is commercial with a share about 67%, followed by clinical and preclinical.
This report aims to provide a comprehensive presentation of the global market for Lipid Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Contract Manufacturing.
The Lipid Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lipid Contract Manufacturing Market Report

Report Metric Details
Report Name Lipid Contract Manufacturing Market
Accounted market size in year US$ 824 million
Forecasted market size in 2031 US$ 770 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Liposomes
  • Lipid Nanoparticles
Segment by Application
  • Preclinical
  • Clinical
  • Commercial
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, Acuitas Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lipid Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Lipid Contract Manufacturing Market size in 2031?

Ans: The Lipid Contract Manufacturing Market size in 2031 will be US$ 770 million.

What is the market share of major companies in Lipid Contract Manufacturing Market?

Ans: The top 3 companies hold a share about 38%.

What is the Lipid Contract Manufacturing Market share by region?

Ans: North America is the largest market, with a share over 60%, followed by Europe and APAC with the share about 26% and 12%.

What is the Lipid Contract Manufacturing Market share by type?

Ans: In terms of product, lipid nanoparticles is the largest segment with a share about 79%.

Who are the main players in the Lipid Contract Manufacturing Market report?

Ans: The main players in the Lipid Contract Manufacturing Market are Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, Acuitas Therapeutics

What are the Application segmentation covered in the Lipid Contract Manufacturing Market report?

Ans: The Applications covered in the Lipid Contract Manufacturing Market report are Preclinical, Clinical, Commercial

What are the Type segmentation covered in the Lipid Contract Manufacturing Market report?

Ans: The Types covered in the Lipid Contract Manufacturing Market report are Liposomes, Lipid Nanoparticles

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Market by Application
1.3.1 Global Lipid Contract Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid Contract Manufacturing Market Perspective (2020-2031)
2.2 Global Lipid Contract Manufacturing Growth Trends by Region
2.2.1 Global Lipid Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lipid Contract Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Lipid Contract Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Lipid Contract Manufacturing Market Dynamics
2.3.1 Lipid Contract Manufacturing Industry Trends
2.3.2 Lipid Contract Manufacturing Market Drivers
2.3.3 Lipid Contract Manufacturing Market Challenges
2.3.4 Lipid Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid Contract Manufacturing Players by Revenue
3.1.1 Global Top Lipid Contract Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Lipid Contract Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Lipid Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lipid Contract Manufacturing Revenue
3.4 Global Lipid Contract Manufacturing Market Concentration Ratio
3.4.1 Global Lipid Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid Contract Manufacturing Revenue in 2024
3.5 Global Key Players of Lipid Contract Manufacturing Head office and Area Served
3.6 Global Key Players of Lipid Contract Manufacturing, Product and Application
3.7 Global Key Players of Lipid Contract Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipid Contract Manufacturing Breakdown Data by Type
4.1 Global Lipid Contract Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Lipid Contract Manufacturing Forecasted Market Size by Type (2026-2031)
5 Lipid Contract Manufacturing Breakdown Data by Application
5.1 Global Lipid Contract Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Lipid Contract Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lipid Contract Manufacturing Market Size (2020-2031)
6.2 North America Lipid Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lipid Contract Manufacturing Market Size by Country (2020-2025)
6.4 North America Lipid Contract Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid Contract Manufacturing Market Size (2020-2031)
7.2 Europe Lipid Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lipid Contract Manufacturing Market Size by Country (2020-2025)
7.4 Europe Lipid Contract Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipid Contract Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Lipid Contract Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lipid Contract Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Lipid Contract Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipid Contract Manufacturing Market Size (2020-2031)
9.2 Latin America Lipid Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lipid Contract Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Lipid Contract Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid Contract Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Lipid Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Details
11.1.2 Precision NanoSystems Business Overview
11.1.3 Precision NanoSystems Lipid Contract Manufacturing Introduction
11.1.4 Precision NanoSystems Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.1.5 Precision NanoSystems Recent Development
11.2 Evonik
11.2.1 Evonik Company Details
11.2.2 Evonik Business Overview
11.2.3 Evonik Lipid Contract Manufacturing Introduction
11.2.4 Evonik Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.2.5 Evonik Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Lipid Contract Manufacturing Introduction
11.3.4 Merck KGaA Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Details
11.4.2 Genevant Sciences Business Overview
11.4.3 Genevant Sciences Lipid Contract Manufacturing Introduction
11.4.4 Genevant Sciences Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.4.5 Genevant Sciences Recent Development
11.5 Exelead
11.5.1 Exelead Company Details
11.5.2 Exelead Business Overview
11.5.3 Exelead Lipid Contract Manufacturing Introduction
11.5.4 Exelead Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.5.5 Exelead Recent Development
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Details
11.6.2 Avanti Polar Lipids Business Overview
11.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Introduction
11.6.4 Avanti Polar Lipids Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.6.5 Avanti Polar Lipids Recent Development
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Details
11.7.2 Nippon Fine Chemical Business Overview
11.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Introduction
11.7.4 Nippon Fine Chemical Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.7.5 Nippon Fine Chemical Recent Development
11.8 Lipoid
11.8.1 Lipoid Company Details
11.8.2 Lipoid Business Overview
11.8.3 Lipoid Lipid Contract Manufacturing Introduction
11.8.4 Lipoid Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.8.5 Lipoid Recent Development
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Details
11.9.2 Polymun Scientific Business Overview
11.9.3 Polymun Scientific Lipid Contract Manufacturing Introduction
11.9.4 Polymun Scientific Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.9.5 Polymun Scientific Recent Development
11.10 Corden Pharma
11.10.1 Corden Pharma Company Details
11.10.2 Corden Pharma Business Overview
11.10.3 Corden Pharma Lipid Contract Manufacturing Introduction
11.10.4 Corden Pharma Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.10.5 Corden Pharma Recent Development
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Details
11.11.2 Acuitas Therapeutics Business Overview
11.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Introduction
11.11.4 Acuitas Therapeutics Revenue in Lipid Contract Manufacturing Business (2020-2025)
11.11.5 Acuitas Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lipid Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Liposomes
 Table 3. Key Players of Lipid Nanoparticles
 Table 4. Global Lipid Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Lipid Contract Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Lipid Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Lipid Contract Manufacturing Market Share by Region (2020-2025)
 Table 8. Global Lipid Contract Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Lipid Contract Manufacturing Market Share by Region (2026-2031)
 Table 10. Lipid Contract Manufacturing Market Trends
 Table 11. Lipid Contract Manufacturing Market Drivers
 Table 12. Lipid Contract Manufacturing Market Challenges
 Table 13. Lipid Contract Manufacturing Market Restraints
 Table 14. Global Lipid Contract Manufacturing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Lipid Contract Manufacturing Market Share by Players (2020-2025)
 Table 16. Global Top Lipid Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Contract Manufacturing as of 2024)
 Table 17. Ranking of Global Top Lipid Contract Manufacturing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Lipid Contract Manufacturing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Lipid Contract Manufacturing, Headquarters and Area Served
 Table 20. Global Key Players of Lipid Contract Manufacturing, Product and Application
 Table 21. Global Key Players of Lipid Contract Manufacturing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Lipid Contract Manufacturing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Lipid Contract Manufacturing Revenue Market Share by Type (2020-2025)
 Table 25. Global Lipid Contract Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Lipid Contract Manufacturing Revenue Market Share by Type (2026-2031)
 Table 27. Global Lipid Contract Manufacturing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Lipid Contract Manufacturing Revenue Market Share by Application (2020-2025)
 Table 29. Global Lipid Contract Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Lipid Contract Manufacturing Revenue Market Share by Application (2026-2031)
 Table 31. North America Lipid Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Lipid Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Lipid Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Lipid Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Lipid Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Lipid Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Lipid Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Lipid Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Lipid Contract Manufacturing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lipid Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Lipid Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Lipid Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Lipid Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Precision NanoSystems Company Details
 Table 47. Precision NanoSystems Business Overview
 Table 48. Precision NanoSystems Lipid Contract Manufacturing Product
 Table 49. Precision NanoSystems Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 50. Precision NanoSystems Recent Development
 Table 51. Evonik Company Details
 Table 52. Evonik Business Overview
 Table 53. Evonik Lipid Contract Manufacturing Product
 Table 54. Evonik Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 55. Evonik Recent Development
 Table 56. Merck KGaA Company Details
 Table 57. Merck KGaA Business Overview
 Table 58. Merck KGaA Lipid Contract Manufacturing Product
 Table 59. Merck KGaA Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 60. Merck KGaA Recent Development
 Table 61. Genevant Sciences Company Details
 Table 62. Genevant Sciences Business Overview
 Table 63. Genevant Sciences Lipid Contract Manufacturing Product
 Table 64. Genevant Sciences Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 65. Genevant Sciences Recent Development
 Table 66. Exelead Company Details
 Table 67. Exelead Business Overview
 Table 68. Exelead Lipid Contract Manufacturing Product
 Table 69. Exelead Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 70. Exelead Recent Development
 Table 71. Avanti Polar Lipids Company Details
 Table 72. Avanti Polar Lipids Business Overview
 Table 73. Avanti Polar Lipids Lipid Contract Manufacturing Product
 Table 74. Avanti Polar Lipids Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 75. Avanti Polar Lipids Recent Development
 Table 76. Nippon Fine Chemical Company Details
 Table 77. Nippon Fine Chemical Business Overview
 Table 78. Nippon Fine Chemical Lipid Contract Manufacturing Product
 Table 79. Nippon Fine Chemical Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 80. Nippon Fine Chemical Recent Development
 Table 81. Lipoid Company Details
 Table 82. Lipoid Business Overview
 Table 83. Lipoid Lipid Contract Manufacturing Product
 Table 84. Lipoid Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 85. Lipoid Recent Development
 Table 86. Polymun Scientific Company Details
 Table 87. Polymun Scientific Business Overview
 Table 88. Polymun Scientific Lipid Contract Manufacturing Product
 Table 89. Polymun Scientific Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 90. Polymun Scientific Recent Development
 Table 91. Corden Pharma Company Details
 Table 92. Corden Pharma Business Overview
 Table 93. Corden Pharma Lipid Contract Manufacturing Product
 Table 94. Corden Pharma Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 95. Corden Pharma Recent Development
 Table 96. Acuitas Therapeutics Company Details
 Table 97. Acuitas Therapeutics Business Overview
 Table 98. Acuitas Therapeutics Lipid Contract Manufacturing Product
 Table 99. Acuitas Therapeutics Revenue in Lipid Contract Manufacturing Business (2020-2025) & (US$ Million)
 Table 100. Acuitas Therapeutics Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Lipid Contract Manufacturing Picture
 Figure 2. Global Lipid Contract Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lipid Contract Manufacturing Market Share by Type: 2024 VS 2031
 Figure 4. Liposomes Features
 Figure 5. Lipid Nanoparticles Features
 Figure 6. Global Lipid Contract Manufacturing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lipid Contract Manufacturing Market Share by Application: 2024 VS 2031
 Figure 8. Preclinical Case Studies
 Figure 9. Clinical Case Studies
 Figure 10. Commercial Case Studies
 Figure 11. Lipid Contract Manufacturing Report Years Considered
 Figure 12. Global Lipid Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Lipid Contract Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Lipid Contract Manufacturing Market Share by Region: 2024 VS 2031
 Figure 15. Global Lipid Contract Manufacturing Market Share by Players in 2024
 Figure 16. Global Top Lipid Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Contract Manufacturing as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Lipid Contract Manufacturing Revenue in 2024
 Figure 18. North America Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Lipid Contract Manufacturing Market Share by Country (2020-2031)
 Figure 20. United States Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Lipid Contract Manufacturing Market Share by Country (2020-2031)
 Figure 24. Germany Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Lipid Contract Manufacturing Market Share by Region (2020-2031)
 Figure 32. China Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Lipid Contract Manufacturing Market Share by Country (2020-2031)
 Figure 40. Mexico Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Lipid Contract Manufacturing Market Share by Country (2020-2031)
 Figure 44. Turkey Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Lipid Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Precision NanoSystems Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 48. Evonik Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 49. Merck KGaA Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 50. Genevant Sciences Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 51. Exelead Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 52. Avanti Polar Lipids Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 53. Nippon Fine Chemical Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 54. Lipoid Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 55. Polymun Scientific Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 56. Corden Pharma Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 57. Acuitas Therapeutics Revenue Growth Rate in Lipid Contract Manufacturing Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart